SEC 13F Intelligence

Duquesne Family Office LLC / NAMS

Duquesne Family Office LLC’s Newamsterdam Pharma Company Position

Does Duquesne Family Office LLC own Newamsterdam Pharma Company (NAMS)? Yes — 3.07M shares worth $98M (+2.91% of its 13F portfolio) as of Q1 2026.

Position Value
$98M
Q1 2026
Shares
3.07M
% of Portfolio
+2.91%
Quarters Held
7
currently held

Position History NAMS

Reported value by quarter
Q3 ’24: $5MQ3 ’24Q4 ’24: $7MQ4 ’24Q1 ’25: $16MQ1 ’25Q2 ’25: $15MQ2 ’25Q3 ’25: $55MQ3 ’25Q4 ’25: $108MQ4 ’25Q1 ’26: $98MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20263.07M$98M+2.91%
Q4 20253.07M$108M+2.40%
Q3 20251.92M$55M+1.35%
Q2 2025832.2K$15M+0.37%
Q1 2025800.4K$16M+0.54%
Q4 2024287.5K$7M+0.20%
Q3 2024287.5K$5M+0.16%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Duquesne Family Office LLC’s full portfolio or all institutional holders of NAMS.